Rare Disease Sleep Pilot Research Plan
Rare Disease Sleep Pilot Research Plan
批准号:
8153422
负责人:
DANIEL G. GLAZE
金额:
$27.08万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2014-07-31
关键词:
AdenoidectomyAdultAdverse effectsAgeAngelman SyndromeAnxietyBehaviorBehavior TherapyBehavioralBrainBruxismChildChronic DiseaseCircadian RhythmsClinicClinicalCognitiveConfusional ArousalsDataDevelopmentDiseaseEvaluationFamilyGenotypeHealthImpairmentIncentivesIndividualInterventionInterviewIronLeadLearningLife Cycle StagesLongitudinal StudiesMedicalMedicineMelatoninMemoryMentally Disabled PersonsNatureNeuronal PlasticityNight TerrorsObstructive Sleep ApneaOralParticipantPerformancePharmaceutical PreparationsPilot ProjectsPolysomnographyPopulationPrader-Willi SyndromePrevalenceQuality of lifeQuestionnairesRare DiseasesRecruitment ActivityResearchResistanceRett SyndromeRiskRoleSeveritiesSiteSleepSleep Apnea SyndromesSleep DisordersSleep disturbancesSleeplessnessSomatotropinSomnambulismSpecialistSyndromeTonsillectomyTreatment outcomebaseeffective therapyhigh riskhormone therapyimprovedlimb movementnervous system disorderneurogenesisnovel diagnosticssleep abnormalitiesstandard of caretreatment strategy
中文摘要
VII.iii.罕见疾病睡眠试点研究计划
A.简介:
睡眠对健康的重要性近年来逐渐显现。睡眠障碍的范围
儿童是广泛的,尽管睡眠与正常发育和慢性疾病的相关性不是很好
明白最近,睡眠在学习、记忆、神经发生和神经可塑性中的关键作用已经被发现。
睡眠对大脑功能和大脑发育的重要性[1]。一致认为,
睡眠障碍(睡眠呼吸暂停、失眠、梦游、夜惊、意识模糊觉醒、周期性肢体
运动(PLMS)和磨牙症)对儿童的生活质量及其
家庭患有神经系统疾病的人特别危险,因为睡眠中断会导致
日间行为加剧,导致认知能力差[2]。重要的是要了解
神经系统疾病儿童睡眠障碍的性质,因为这可能具有重要意义
生活质量和智力功能受损的程度。在睡眠和睡眠之间
问题和行为障碍将有助于这种理解。
正常人群中睡眠问题的患病率估计在18-37%之间,
研究[3,4]。对智力落后者的问卷调查和访谈表明,
大约15-50%的成年人和30-67%的儿童有睡眠问题5 '6
Angelman综合征(AS)、Rett综合征(RTT)和Prader-Willi综合征(PWS)的睡眠异常。
英文摘要
VII.iii. Rare Disease Sleep Pilot Research Plan
A. Introduction:
The importance of sleep to proper health has emerged in recent years. The range of sleep disorders in
children is broad, although the relevance of sleep to normal development and chronic illness is not well
understood. Recently, critical roles for sleep in learning, memory, neurogenesis, and neural plasticity have
been described, underlying the importance of sleep to brain function and brain development[1]. Consistently,
sleep disturbances (sleep apnea, insomnia, sleepwalking, night terrors, confusional arousals, periodic limb
movements (PLMS), and bruxism) have significant adverse effects on the quality of life of children and their
families. Individuals with neurological disease are at particular risk because sleep disruptions lead to
exacerbation of daytime behaviors and result in poor cognitive performance[2]. It is important to understand the
nature of sleep impairments in children with neurological disorders, since this may have important implications
for the degree of impairment of quality of life and intellectual functioning. Any understanding between sleep
problems and behavioral disturbances would aid such understanding.
The prevalence of sleep problems in the normal population is estimated to be between 18-37% in different
Studies[3,4]. Questionnaire and interview based studies among mentally retarded subjects show that
approximately 15-50% of adults and 30-67% of children have sleep problems5'6 There are very little data on
sleep abnormalities in Angelman syndrome (AS), Rett syndrome (RTT), and Prader-Willi syndrome (PWS).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rare Disease Sleep Pilot Research Plan
-
批准号:8381943
-
项目类别:
-
资助金额:$17.32万
-
财政年份:2012
-
负责人:DANIEL G. GLAZE
-
依托单位:
Rare Disease Sleep Pilot Research Plan
-
批准号:8142869
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2010
-
负责人:DANIEL G. GLAZE
-
依托单位:
Rare Disease Sleep Pilot Research Plan
-
批准号:7877171
-
项目类别:
-
资助金额:$17.29万
-
财政年份:2009
-
负责人:DANIEL G. GLAZE
-
依托单位:
RETT SYNDROME NATURAL HISTORY CLINICAL PROTOCOL
-
批准号:8166675
-
项目类别:
-
资助金额:$3.36万
-
财政年份:2009
-
负责人:DANIEL G. GLAZE
-
依托单位:
RETT SYNDROME NATURAL HISTORY CLINICAL PROTOCOL
-
批准号:7950620
-
项目类别:
-
资助金额:$3.35万
-
财政年份:2008
-
负责人:DANIEL G. GLAZE
-
依托单位:
RETT SYNDROME NATURAL HISTORY CLINICAL PROTOCOL
-
批准号:7605914
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2007
-
负责人:DANIEL G. GLAZE
-
依托单位:
CLINICAL PATHOPHYSIOLOGY OF RETT SYNDROME
-
批准号:7206724
-
项目类别:
-
资助金额:$1.44万
-
财政年份:2004
-
负责人:DANIEL G. GLAZE
-
依托单位:
PHARMACODYNAMIC EVALUATION OF THREE DIFFERENT ZOLPIDEM DOSES IN CHILDREN
-
批准号:7206762
-
项目类别:
-
资助金额:$1.81万
-
财政年份:2004
-
负责人:DANIEL G. GLAZE
-
依托单位:
Treatment of Rett Syndrome with Folate and Betaine
-
批准号:7041646
-
项目类别:
-
资助金额:$6.64万
-
财政年份:2003
-
负责人:DANIEL G. GLAZE
-
依托单位:
Rare Disease Sleep Pilot Research Plan
-
批准号:8337263
-
项目类别:
-
资助金额:$4.42万
-
财政年份:2003
-
负责人:DANIEL G. GLAZE
-
依托单位:
Rett Syndrome Open Trial of Folate and Betaine
-
批准号:7041666
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2003
-
负责人:DANIEL G. GLAZE
-
依托单位:
Pharmacodynamics /Three Different Zolpidem Doses /Childr
-
批准号:7041699
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2003
-
负责人:DANIEL G. GLAZE
-
依托单位:
OBSTRUCTIVE SLEEP APNEA IN CHILDREN
-
批准号:6390306
-
项目类别:
-
资助金额:$41.32万
-
财政年份:1999
-
负责人:DANIEL G. GLAZE
-
依托单位:
OBSTRUCTIVE SLEEP APNEA IN CHILDREN
-
批准号:6184647
-
项目类别:
-
资助金额:$41.32万
-
财政年份:1999
-
负责人:DANIEL G. GLAZE
-
依托单位:
OBSTRUCTIVE SLEEP APNEA IN CHILDREN
-
批准号:2831262
-
项目类别:
-
资助金额:$41.32万
-
财政年份:1999
-
负责人:DANIEL G. GLAZE
-
依托单位:
OBSTRUCTIVE SLEEP APNEA IN CHILDREN
-
批准号:6527550
-
项目类别:
-
资助金额:$41.32万
-
财政年份:1999
-
负责人:DANIEL G. GLAZE
-
依托单位:
CORE--PATIENT ASSESSMENT, DATA ANALYSIS/MANAGEMENT
-
批准号:6241061
-
项目类别:
-
资助金额:$5.01万
-
财政年份:1997
-
负责人:DANIEL G. GLAZE
-
依托单位:
RETT SYNDROME: PROGRAM PROJECT
-
批准号:2199099
-
项目类别:
-
资助金额:$74.83万
-
财政年份:1988
-
负责人:DANIEL G. GLAZE
-
依托单位:
RETT SYNDROME--PROGRAM PROJECT
-
批准号:2199098
-
项目类别:
-
资助金额:$67.77万
-
财政年份:1988
-
负责人:DANIEL G. GLAZE
-
依托单位:
RETT SYNDROME--PROGRAM PROJECT
-
批准号:3097141
-
项目类别:
-
资助金额:$69.4万
-
财政年份:1988
-
负责人:DANIEL G. GLAZE
-
依托单位:
海外基金